Navigation Links
Reduction in Antidepressant Leads to Suicidal Risks

Regulatory warnings regarding the risk of suicidal thoughts and behaviors appear to be associated with reductions in the number of antidepressant medication prescriptions among children and adolescents covered by Tennessees expanded Medicaid program.

Antidepressant medications are frequently used to treat depression among children and teens, but in 2003 data emerged regarding an increased risk of suicidal thinking and behavior among young patients taking these drugs, according to background information in the article.

In December 2003, the Committee on Safety of Medicines [the U.K. drug regulatory agency] declared the risk-benefit profile of all selective serotonin reuptake inhibitor (SSRI) antidepressants (as well as venlafaxine hydrochloride and mirtazapine), with the exception of fluoxetine, to be unfavorable for the treatment of major depressive disorders in children and adolescents, the authors write.

Shortly thereafter in 2004, the Food and Drug Administration convened a Psychopharmacology Advisory Committee meeting in February, issued a public health advisory in March, and in October required black box warning labels for all antidepressants (including fluoxetine) highlighting the potential increase in suicidal thinking and behavior in children and adolescents.

The warning recommended more intense therapeutic monitoring to mitigate these risks but did not suggest avoiding the pediatric use of antidepressants.

Benji T. Kurian, M.D., M.P.H., and colleagues at Vanderbilt University School of Medicine, Nashville, Tenn., examined monthly antidepressant prescription data among patients age 2 to 17 years covered by the TennCare expanded Medicare program. The study included the 45 months from Jan. 1, 2002, through Sept. 30, 2005, 12 months following the FDA black box warning, the authors write.

The study months were divided into two periods. The period before the regulatory warnings incl uded the 24 months from Jan. 1, 2002, through Dec. 31, 2003, and that after the regulatory warnings included the 21 months from Jan. 1, 2004, through Sept. 30, 2005. An average of 405,000 children and teens qualified for the study each month.

During the period before the regulatory warnings, there was little change from month to month in the rate of new antidepressant prescriptions, with an average of 23 per 10,000 patients. By the end of the studya total of 21 months after the U.K. warningsthis proportion had decreased by 33 percent to an average of 15 per 10,000 per month.

The decrease was most pronounced for SSRIs (except for fluoxetine) and another type of antidepressant linked to suicidal thoughts and behaviors, selective norepinephrine reuptake inhibitors.

New users of fluoxetine, the only antidepressant approved by the FDA for the treatment of depression in children and adolescents, increased by 60 percent. However, there was no evidence of an increase in discontinuations of therapy with antidepressant or other psychotropic drugs, which suggests that the primary effect of the warnings was to alter the decision to treat a newly presenting patient, the authors write.

Previous studies have shown that the use of antidepressants among TennCare patients is similar to that of children and adolescents in the entire United States, suggesting that a similar decrease may have occurred in other populations.

Because there is so much uncertainly regarding the pediatric use of antidepressants, the implications of these changes are unclear, the authors note. Thus, while it is now evident that regulatory interventions can alter patterns of practice, whether this is desirable is uncertain, they conclude. There is an urgent need for better data on the efficacy and safety of antidepressants to guide pediatric practice.


'"/>




Related medicine news :

1. Reduction in melanoma death rate
2. A Reduction In Calories Found To Yield More Benefits
3. Weight Reduction Surgery Also Treats Metabolic Syndrome
4. Changing Trends Regarding Insurance Cover For Weight Reduction Surgery
5. A Change In Lifestyle Can Help In Weight Reduction
6. Fat isnt all that bad: Reduction no predecessor of reduced disease
7. MP’s Ask for Reduction of VAT on Condoms, Essential Health Ite
8. Drugs plus Awareness Would Facilitate Reduction of HIV Infection
9. Heart Disease Risk Halved By Minimal Cholesterol Reduction
10. Waiting Period Of Over 10yrs For Women Needing Breast Reduction Surgery
11. After Weight Reduction People Opt For Special Plastic Surgery to Tone Their Body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, ... of the health care industry’s hospitals and provider groups, has announced that it ... select customers. Parasail Health is a San Francisco health-finance startup that has launched ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article on medGadget ... $6.81 billion by the year 2024 according to a new report. The article also ... made from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center ...
(Date:6/27/2017)... Portland, Ore. (PRWEB) , ... June 27, 2017 ... ... Provider (CSP), today announced the expansion of Atmosera Managed Azure Services . ... now includes enhancements in support of the company’s growing customer base. Atmosera’s next ...
(Date:6/27/2017)... ... ... Today, June 27th is PTSD Awareness Day. Over half a million U.S. ... care due to lack of effective treatments, fear of stigma or insufficient government resources. ... veterans are at an increased risk for self-destructive behavior, including alcohol/drug abuse, depression, anxiety ...
(Date:6/26/2017)... ... ... Torrance dentist, Dr. Robert Mondavi DDS , is now offering comprehensive ... a person’s appearance. A healthy, radiant smile can make a person look more attractive, ... have the smile of their dreams with cosmetic dentistry. , “The field of dentistry ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
(Date:6/14/2017)... 2017  In 2016, Embodied Labs took ... competition and came away with $25,000 in seed-fund investment. ... Forbes as "entering the life of another" and by ... "empathy to medical professionals in an entirely new dimension." ... a finalist for the Department of Education,s EdSimChallenge, where ...
(Date:6/12/2017)... -- Kineta, Inc., a biotechnology company focused on the development ... of R&D and Head of Virology Kristin Bedard has been ... Northwest and Beyond meeting sponsored by Life Science Washington. ... 8:30-10:30 AM PDT at the Agora Conference Center in ... will be joined by other leaders in infectious disease research ...
Breaking Medicine Technology: